Reviews, Commentaries, etc. - NAKAHARA Jin

Correction to: Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis (BMC Neurology, (2025), 25, 1, (1), 10.1186/s12883-024-04009-z)

Tokuyasu D., Imai S., Chen S.P., Ihara K., Watanabe N., Izawa Y., Nakahara J., Hori S., Takizawa T.

BMC Neurology 25 ( 1 )  2025.12

　View Summary

Following publication of the original article [1], the authors identified an error in the author name of Shih-Pin Chen. The incorrect author name is: Shin-Pin Chen The correct author name is: Shih-Pin Chen The author group has been updated above and the original article [1] has been corrected.

• Access to Document (DOI)

A Cautionary Note on the Indication for Deep Brain Stimulation in Parkinsonism Patients With SLC9A6 Gene Mutations

Okusa S., Tezuka T., Kosugi K., Yamamoto Y., Takahata K., Higuchi M., Akiyama T., Kobayashi M., Toda M., Ito D., Nakahara J., Seki M.

Journal of Movement Disorders 18 ( 3 ) 268 - 270 2025.07

ISSN  2005940X

• Access to Document (DOI)

Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report

Nukariya T., Tezuka T., Okusa S., Okochi R., Sakai Y., Nihei Y., Nakahara J., Seki M.

Journal of Movement Disorders 18 ( 2 ) 179 - 181 2025.04

ISSN  2005940X

• Access to Document (DOI)

Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/ Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report

Tezuka T., Nukariya T., Kizuka Y., Okusa S., Okochi R., Sakai Y., Nihei Y., Nakahara J., Seki M.

Journal of Movement Disorders 17 ( 4 ) 453 - 455 2024.10

ISSN  2005940X

• Access to Document (DOI)

Potential benefits and possible risks of CGRP-targeted multitherapy in migraine

Ihara K., Takizawa T., Watanabe N., Nakahara J., Martelletti P.

Expert Opinion on Drug Metabolism and Toxicology (Expert Opinion on Drug Metabolism and Toxicology)  20 ( 1-2 ) 1 - 4 2024

ISSN  17425255

• Access to Document (DOI)

Correction to: Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder (Neurology and Therapy, (2024), 13, 3, (535-549), 10.1007/s40120-024-00597-7)

Clardy S.L., Pittock S.J., Aktas O., Nakahara J., Isobe N., Centonze D., Fam S., Kielhorn A., Yu J.C., Jansen J., Zhang I.

Neurology and Therapy (Neurology and Therapy)  13 ( 4 ) 1313 - 1314 2024

ISSN  21938253

　View Summary

In Fig. 3 of this article, the top row of the Forest plot should show the right end of the confidence interval to align with a value of 0.71; the correct figure is shown below (Fig. 3). (Figure presented.) Forest plot of NMA results for time-to-first relapse with ravulizumab versus alternate interventions in adults with AQP4-Ab+ NMOSD. In SAkuraSky and PREVENT, background IST such as azathioprine, mycophenolate mofetil, and glucocorticoids were allowed, whereas IST was explicitly excluded from the N-MOmentum and SAkuraStar population. AQP4-Ab+ anti-aquaporin-4 antibody-positive, CrI credible interval, IST immunosuppressive therapy, NMOSD neuromyelitis optica spectrum disorder The original article has been corrected.

• Access to Document (DOI)

Response to letter: “Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule” by Suzuki et al.

Ihara K., Ohtani S., Watanabe N., Takahashi N., Hori S., Nakahara J., Takizawa T.

Journal of the Neurological Sciences (Journal of the Neurological Sciences)  455 2023.12

ISSN  0022510X

• Access to Document (DOI)

Flare of myasthenia gravis induced by COVID-19 vaccines

Ishizuchi K., Takizawa T., Sekiguchi K., Motegi H., Oyama M., Nakahara J., Suzuki S.

Journal of the Neurological Sciences (Journal of the Neurological Sciences)  436 2022.05

ISSN  0022510X

• Access to Document (DOI)

Progressive Ataxia and Palatal Tremor Showing Characteristic Tau Depositions in [¹⁸F]PM-PBB3 PET

Tezuka T., Takahata K., Tagai K., Ueda R., Ito D., Takeda H., Takahashi S., Nakahara J., Higuchi M., Seki M.

Movement Disorders (Movement Disorders)  37 ( 6 ) 1317 - 1319 2022

ISSN  08853185

• Access to Document (DOI)

Time to revisit B cells in multiple sclerosis

Nakahara J.

Clinical and Experimental Neuroimmunology (Clinical and Experimental Neuroimmunology)  12 ( 4 )  2021.11

• Access to Document (DOI)

A case of progressive supranuclear palsy with predominant cerebellar ataxia diagnosed by [¹⁸F]PM-PBB3 tau PET

Ishizuchi K., Takizawa T., Tezuka T., Takahata K., Seki M., Tabuchi H., Ueda R., Kubota M., Mimura M., Nakahara J., Ito D.

Journal of the Neurological Sciences (Journal of the Neurological Sciences)  425 2021.06

ISSN  0022510X

• Access to Document (DOI)